What is the recommended treatment regimen for an adult or adolescent patient with HIV-1 infection, considering the use of Dolutegravir?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the preferred treatment between efavirenz and dolutegravir for HIV-1 (Human Immunodeficiency Virus type 1) infection?
Is it okay to use dolutegravir (Integrase Strand Transfer Inhibitor) in a patient with resistance to efavirenz (Non-Nucleoside Reverse Transcriptase Inhibitor)?
Can I combine dolutegravir with other Antiretroviral Therapy (ART) medications?
What is the treatment for Tivicay (dolutegravir) exposure?
What class of antiretroviral is Dolutegravir?
What is the cause of a patient's numbness, speech difficulties, and neurological symptoms, who is taking phentermine (37.5 mg) and topiramate (25 mg) for weight loss, with normal MRI results and no signs of stroke?
What are the 4 pillars of medication for a patient with Chronic Kidney Disease (CKD)?
What is the difference between Breztri (budesonide/glycopyrrolate/formoterol) and Symbicort (budesonide/formoterol) for a patient with chronic obstructive pulmonary disease (COPD) or asthma?
Is metronidazole effective against hydrogen-producing or methane-producing Small Intestine Bacterial Overgrowth (SIBO) in a patient with a history of vitamin B12 deficiency?
What is the best approach for weight loss in a patient with type 2 diabetes and a body mass index (BMI) of 30 kg/m² or higher, considering pharmacotherapy with Mounjaro (tirzepatide)?
Can a patient with Duchenne muscular dystrophy (DMD) and an ivs21-2 A>C transversion mutation experience variable disease severity due to alternative splicing of the dystrophin gene, resulting in some muscle fibers being less affected than others?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.